Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring
NCT01752231 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2017-12-21
Summary
This pilot clinical trial studies dynamic contrast enhanced (DCE)-magnetic resonance imaging (MRI) in diagnosing cancer. New diagnostic procedures, such as DCE-MRI may help find and diagnose cancer
Conditions
- Normal Volunteers
Sponsors & Collaborators
-
City of Hope Medical Center
lead OTHER
Principal Investigators
-
Jinha Park, MD, Ph.D. · City of Hope Medical Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-23
- Primary Completion
- 2017-08-29
- Completion
- 2017-08-29
Countries
- United States
Study Locations
More Related Trials
-
Functional Imaging of Tumor and Normal Tissue
NCT00933114 ·Status: TERMINATED
-
MRI Assessment of Leukemia Response to Therapy
NCT01537159 ·Status: COMPLETED
-
Imaging Study Compare 4DCT Image
NCT01626001 ·Status: COMPLETED ·Phase: PHASE1
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
NCT02277561 ·Status: WITHDRAWN ·Phase: NA
-
Quantitative MRI in Assessing Disease in Patients With Brain Tumors
NCT02269111 ·Status: TERMINATED ·Phase: NA
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
NCT02156739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
DCE MRI in Patients With Pancreatic Cancer
NCT02070705 ·Status: TERMINATED ·Phase: NA
-
The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients
NCT05855278 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
NCT03145077 ·Status: RECRUITING ·Phase: NA
-
Demonstration Of A Next Generation PET CT System
NCT05122715 ·Status: UNKNOWN ·Phase: NA
-
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
NCT00946140 ·Status: COMPLETED
-
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
NCT05844306 ·Status: SUSPENDED ·Phase: NA
-
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905 ·Status: UNKNOWN ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Advanced MRI Sequences for Radiation Therapy Treatment Planning
NCT02340715 ·Status: COMPLETED
-
FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
NCT02317302 ·Status: TERMINATED ·Phase: PHASE1
-
PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients
NCT05855291 ·Status: COMPLETED ·Phase: NA
-
Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
NCT02354326 ·Status: TERMINATED
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA
-
MRI (Including Spectroscopy and Fat-Saturations and Diffusion-Weighted Imaging) in Cervical Cancer
NCT01060033 ·Status: COMPLETED ·Phase: NA
-
MR/PET in the Evaluation of Patients With Esophageal Cancer
NCT02547610 ·Status: UNKNOWN
-
The Predictive Value of CT-PET in Esophageal Cancer
NCT02385604 ·Status: COMPLETED